Clinical Associate, Laboratory of Clinical Psychopharmacology, Division of
Special Mental Health Research, Intramural Research Program, National
Institute of Mental Health, Saint Elizabeths Hospital, Washington, D.C.
Staff Psychiatrist, Adult Psychiatry Branch (formerly Laboratory of Clinical
Psychopharmacology, Division of Special Mental Health Research), Intramural
Research Program, National Institute of Mental Health, Saint Elizabeths Hospital,
Washington, D.C.
Chief, Clinical Brain Studies Section, Neuropsychiatry Branch (formerly Adult
Psychiatry Branch), Intramural Research Program, National Institute of Mental
Health, Saint Elizabeths Hospital, Washington, D.C.
Deputy Chief, Clinical Brain Disorders Branch and Chief, Neuropathology
Section, Intramural Research Program, National lastitute of Mental Health, Saint
Huzabeths Hospital, Washington, D.C.
Clinical Fellow, University of California Medical School in San Francisco,
California
Clinical Fellow, Harvard Medical School, Boston, Massachusetts
Assistant Clinical Professor, Department of Psychiatry and Behavioral Sciences,
George Washington University School of Medicine,
Washington, D.C.
Associate Clinical Professor, Department of Psychiatry and Behavioral Sciences
and Department of Neurology, George Washington University School of
Medicine, Washington, D.C.
Consultant, Paul A. Dever State School, Taunton, Massachusetts
Consultant, Montgomery County Department of Corrections and Rehabilitation,
Rockville, Maryland
Society of Biological Psychiatry, Vice President, 1991-2 President-Elect 1992-3; President, 1993-present
Society for Neuroscience
Washington Psychiatric Society
Diplomate of National Medical Board
American Board of Psychiatry and Neurology, 1978
State Medical Licensure: Maryland, California, District of Columbia, Virginia
AE Bennett Award, 1981
U.S.PHS., Outstanding Service Medal, 1992
Hoffmann PC, Toon R, Kleinman JE and Heller A: The association of lesion-induced
reductions in brain monoamines with alterations of striatal carbohydrate metabolism. 1
Neurocham 20:69-80, 1973.
The association of reduction in monoamines with carbohydrate metabolism in the brain.
A dissertation submitted to the faculty of the Division of Biological Sciences and the
University of Chicago Pritzker School of Medicine in candidacy for the Degree of Doctor
of Philosophy. Department of Pharmacological and Physiological Sciences, 1974, 79
pages.
Davis GC, Bunney WE Jr., De Fraites EG, Kleinman JE, van Kammen DP, Post RM and
Wyatt R.J: Intravenous naloxone administration in schizophrenia and affective illness.
Science 197:74-76, 1977.
Kleinman JE, Gülm J and Wyatt Rut: A comparison of the phenomenology of
hallucinogens and schizophrenia from some autobiographical accounts.
Schizophr Bull 3:560-586, 1977.
Carman JS, Gillin JC, Murphy DL, Weinberger DR, Kleinman JE, Bigelow LB and Wyatt
Put Effects of a selective inhibitor of type A monoamine oxidase-Lilly 51641
--behavior, sleep and circadian rhythms in depressed and schizophrenic patients.
Comm Psychopharmacol 2:513-523, 1978.
Walker RW, Mandel LR, Kleinman JE, Gälin JC, Wyatt RJ and Vandenheuvel WJA: Improved
selective ion monitoring mass-spectrometric assay for the determination of N, N-
dimethyltryptamine in human blood utilizing capillary column gas chromatography.
Chromatography 162-539-546, 1979.
Gullin JC, Kleinman JE, Nasrallah HA, Bigelow LB, Rogol A, Luchins D, Carman J,
Weinberger D and Wyatt RJ: Inhibition of dopamine synthesis in chronic schizophrenia: A follow-
up study. In: Cathecholamines. Basic and Clinical Frontiers. Usdin E, Kopin WJ and Barchas JD
(eds.). Pergamon Press, New York, 1979, pp. 1845-1847.
Kleiaman JE, Bridge P, Karoum F, Speciale S, Staub R, Zalcman S, Gillin JC and
Wyatt RJ: Cathecholamines and metabolites in the brains of psychotics and normals:
Postmortem studies. In: Cathecholamines: Basic and Clinical Frontiers. Usɗin E,
Kopin IJ and Barchas JD (eds.). Pergamon Press, New York 1979, pp. 1845-1847.
Bigelow LB, Zalaman S, Kleinmaa JE, Weinberger D, Luchins D, Tallman J, Karoum F
and Wyatt RJ: Propranolol treatment of chronic schizophrenia: Clinical response.
catecholamine metabolism and lymphocyte B-receptors. In: Catecholamines.
Basic and Clinical Frontiers. Usdin E, Kopin I and Barchas JD (eds.). Pergamon Press,
New York, 1979, pp. 1851-1853.
|